Prime Medicine (PRME) Interest & Investment Income (2023 - 2026)
Prime Medicine (PRME) posted Interest & Investment Income of $1.0 million for Q1 2026, down 5.72% on a QoQ basis from $1.1 million in Q4 2025, and down 13.62% year-over-year from $1.2 million in Q1 2025.
Prime Medicine (PRME) Interest & Investment Income (2023 - 2026) Analysis & Trends
Prime Medicine's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Interest & Investment Income fell 13.62% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 0.99% YoY) and the FY2025 annual result came in at $4.1 million, up 17.8% from the prior year.
- Interest & Investment Income was $1.0 million for Q1 2026 at Prime Medicine, down from $1.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.5 million in Q4 2024 and bottomed at $410000.0 in Q3 2023.
- A 4-year average of $852333.3 and a median of $720000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2024 — Interest & Investment Income surged 213.24% — and 2025, when it decreased 29.58%.
- Prime Medicine's Interest & Investment Income stood at $491000.0 in 2023, then jumped by 213.24% to $1.5 million in 2024, then dropped by 29.58% to $1.1 million in 2025, then decreased by 5.72% to $1.0 million in 2026.
- Business Quant data shows PRME's Interest & Investment Income at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Prime Medicine | 524.20 Mn | 524.20 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 743,000.00 |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 697,000.00 |
| Jun 30, 2024 | 611,000.00 |
| Mar 31, 2024 | 676,000.00 |
| Dec 31, 2023 | 491,000.00 |
| Sep 30, 2023 | 410,000.00 |
| Jun 30, 2023 | 635,000.00 |